Fold change in the observed parameters at 4 hours after the initiation of rituximab infusion compared with the baseline (0 hours). (A) Absolute lymphocyte count. (B) Percentage of NK cells in circulation. (C) NK-cell CD16 median fluorescence intensity. (D) Percentage of CD54^bright NK cells. The single subject with a VV polymorphism is represented as an open square (□).